# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-02T23:34:48.360479
**Route:** OpenRouter + LaTeX
**Tokens:** 21212 in / 1874 out
**Response SHA256:** 756c192fe6429ef0

---

I checked the draft carefully for the specific categories you asked me to screen for fatal problems (data-design alignment, regression sanity, completeness, internal consistency). I found no fatal errors according to the rules you set out. Below are brief confirmations on the key checks I ran.

1) Data–design alignment
- Treatment timing vs data coverage: Treatment date = Nov 30, 2021, and panel covers 2015–2024. Max(treatment year)=2021 ≤ max(data year)=2024. Consistent.
- Post-treatment observations: The paper treats 2022–2024 as full post-treatment years with 2021 as a partial year; those years are present in the data. Event study and post-treatment analyses use 2022–2024. For single-unit SCM on East Harlem the donor pool and placebo logic are applied over pre/post windows consistent with treatment timing. Consistent.
- Treatment definition consistency: Treated units are consistently listed as UHF 201 (Washington Heights) and UHF 203 (East Harlem). The paper clearly indicates when analyses focus on East Harlem alone (single-unit SCM) versus pooled DiD with both treated units. The “first full treatment year = 2022” definition is applied consistently.

2) Regression sanity
- Coefficients and standard errors: No reported coefficients or SEs exceed the plausibility thresholds you specified. Example: DiD Treat×Post = −2.22 with SE = 17.2 — large but plausible given small sample; event-study SEs (e.g., 18.4, 14.2, etc.) are numeric and non-negative. No SEs > 1000, no SEs > 100×|coef| in the sense of obvious model failure (while some SEs are much larger than coefficients, this reflects low power rather than a computational error). No NA/NaN/Inf entries, no R² outside [0,1] reported.
- No negative standard errors; no impossible-looking coefficients (e.g., >100 on log outcomes); no tables with obviously broken numbers.

3) Completeness
- No placeholder strings (NA / TBD / TODO / XXX / PLACEHOLDER) are visible in tables or main text.
- Regression tables report observation counts, number of clusters, and standard errors. Summary statistics table includes Ns. Figures and tables referenced in the text are present in the LaTeX source (as external files referenced), and the text does not refer to non-existent figure/table numbers.
- Methods described have corresponding results (SCM, de-meaned SCM, gsynth, DiD, event study, placebo tests, MSPE inference). Robustness checks and diagnostics are reported.

4) Internal consistency
- Sample and donor-pool definitions are described and applied; the paper is explicit about when the restricted donor pool (5 control UHFs) is used versus larger pools for robustness.
- Timing is applied consistently: pre-treatment = 2015–2020, 2021 treated as partial, post = 2022–2024.
- When analyses focus on East Harlem alone (single-unit SCM and MSPE distribution over its donor pool), the reported unit counts (treated + donors = 6 units total for that analysis) are consistent with how the MSPE ranks and p-values are described. When pooled DiD includes both treated units plus 5 controls, Observations = 7×10 = 70 is reported and consistent with that specification.

Conclusion / verdict
I did not find any fatal errors in the four categories you asked me to check. The issues that remain (large standard errors, low statistical power, provisional 2024 data) are substantive and merit careful discussion in revision but do not constitute the “fatal errors” you asked me to flag.

ADVISOR VERDICT: PASS